The Sucralfate Tablets, cataloged under National Stock Number 6505-01-123-0984, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Greenstone Llc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-123-0984 |
| Primary Part Number | NDC59762-0401-01 |
| Item Name | Sucralfate Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Greenstone Llc |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Features Provided | CHILD RESISTANT CLOSURE |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 1.000 GRAMS SUCRALFATE ACTIVE INGREDIENT G |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC59762-0401-01 PRIMARY | Greenstone Llc (USA) |
| NDC00093-2210-01 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| NDC00591-0780-01 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| NDC62135-0436-41 PRIMARY | Chartwell Rx Llc (USA) |
| Reference | Meaning |
|---|---|
| NDC00591-0780-01 | 5/9 Secondary reference Actavis Elizabeth Llc Dba Actavis Us Div Actavis Pharma, Inc. |
NSN 6505-01-123-0984 is a Sucralfate Tablets, manufactured by Greenstone Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-123-0984 has 4 manufacturer part numbers on file: NDC59762-0401-01 (Greenstone Llc), NDC00093-2210-01 (Teva Pharmaceuticals Usa, Inc.), NDC00591-0780-01 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office), NDC62135-0436-41 (Chartwell Rx Llc).
Key specifications for NDC59762-0401-01: Primary Container Content Quantity: 100.000 TABLETS; Features Provided: CHILD RESISTANT CLOSURE; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: SUCRALFATE TABLETS 1GM 100S BT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.